Literature DB >> 10215125

Determinants of survival in HIV-positive patients.

J Baillargeon1, M Borucki, S A Black, K Dunn.   

Abstract

Variation in the clinical stage at which AIDS is diagnosed has hindered the ability of investigators to generate survival estimates which are stable across study cohorts. As a result, little is known about how clinical and sociodemographic factors are associated with survival, independent of AIDS diagnosis stage. By estimating survival following seroconversion while adjusting for baseline CD4 lymphocyte count, the present study generated survival determinants which were unconfounded by time-related changes in AIDS diagnosis. This study's findings indicate that the following factors were associated with significant decreases in HIV-related survival: older age; self-report of no known HIV transmission risk factors; and presence of cytomegalovirus, Mycobacterium avium complex, and Pneumocystis carinii pneumonia. Furthermore, survival decreased in a monotonic fashion with decreases in baseline CD4 count and with increases in calendar period. While this study's findings are consistent with previous investigators' reports of AIDS survival determinants, it will be important for future investigators to refine and update estimates of HIV-related survival determinants as clinical care for HIV-infected patients continues to improve.

Entities:  

Mesh:

Year:  1999        PMID: 10215125     DOI: 10.1258/0956462991913033

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  7 in total

1.  Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Authors:  C Binquet; F Saillour; N Bernard; M B Rougier; F Leger; F Bonnal; F Dabis
Journal:  Eur J Epidemiol       Date:  2000-05       Impact factor: 8.082

2.  Trends in predictors of death due to HIV-related causes among persons living with AIDS in New York City: 1993-2001.

Authors:  Denis Nash; Monica Katyal; Sarita Shah
Journal:  J Urban Health       Date:  2005-10-19       Impact factor: 3.671

3.  Model for simulation of HIV/AIDS and cost-effectiveness of preventing non-tuberculous mycobacterial (MAC)-disease.

Authors:  Thomas Hoffmann; Helmut Brunner
Journal:  Eur J Health Econ       Date:  2004-06

4.  Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

Authors:  Hamish McManus; Catherine C O'Connor; Mark Boyd; Jennifer Broom; Darren Russell; Kerrie Watson; Norman Roth; Phillip J Read; Kathy Petoumenos; Matthew G Law
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?

Authors:  H McManus; P C K Li; D Nolan; M Bloch; S Kiertiburanakul; J Y Choi; B Mulhall; K Petoumenos; J Zhou; M Law; B J Brew; E Wright
Journal:  HIV Med       Date:  2011-08-07       Impact factor: 3.094

6.  High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.

Authors:  Florence Huber; Alice Merceron; Yoann Madec; Gueda Gadio; Vincent About; Agathe Pastre; Isabelle Coupez; Antoine Adenis; Leila Adriouch; Mathieu Nacher
Journal:  PLoS One       Date:  2017-04-28       Impact factor: 3.240

7.  On the Use of Fractional Polynomial Models to Assess Preventive Aspect of Variables: An Example in Prevention of Mortality Following HIV Infection.

Authors:  Mohammad Reza Baneshi; Fatemeh Nakhaee; Matthew Law
Journal:  Int J Prev Med       Date:  2013-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.